TY - JOUR AU - Siegel, R. AU - Naishadham, D. AU - Jemal, A. PY - 2012 DA - 2012// TI - Cancer statistics, 2012 JO - CA Canc J Clin VL - 62 UR - https://doi.org/10.3322/caac.20138 DO - 10.3322/caac.20138 ID - Siegel2012 ER - TY - JOUR AU - Singh, J. AU - Trabulsi, E. J. AU - Gomella, L. G. PY - 2010 DA - 2010// TI - Is there an optimal management for localized prostate cancer? JO - Clin Interv Aging VL - 5 ID - Singh2010 ER - TY - JOUR AU - Massard, C. AU - Fizazi, K. PY - 2011 DA - 2011// TI - Targeting continued androgen receptor signaling in prostate cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2815 DO - 10.1158/1078-0432.CCR-10-2815 ID - Massard2011 ER - TY - JOUR AU - Bishr, M. AU - Lattouf, J. B. AU - Gannon, P. O. AU - Saad, F. PY - 2011 DA - 2011// TI - Updates on therapeutic targets and agents in castration-resistant prostate cancer JO - Minerva Urol Nefrologica Ital J Orol Nephrol VL - 63 ID - Bishr2011 ER - TY - JOUR AU - Sonpavde, G. AU - Agarwal, N. AU - Choueiri, T. K. AU - Kantoff, P. W. PY - 2011 DA - 2011// TI - Recent advances in immunotherapy for the treatment of prostate cancer JO - Expert Opin Biol Ther VL - 11 UR - https://doi.org/10.1517/14712598.2011.575357 DO - 10.1517/14712598.2011.575357 ID - Sonpavde2011 ER - TY - JOUR AU - Gupta, S. AU - Carballido, E. AU - Fishman, M. PY - 2011 DA - 2011// TI - Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments JO - Oncol Targets Ther VL - 4 ID - Gupta2011 ER - TY - JOUR AU - Cheever, M. A. AU - Higano, C. S. PY - 2011 DA - 2011// TI - PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-3126 DO - 10.1158/1078-0432.CCR-10-3126 ID - Cheever2011 ER - TY - JOUR AU - Bilusic, M. AU - Heery, C. AU - Madan, R. A. PY - 2011 DA - 2011// TI - Immunotherapy in prostate cancer: emerging strategies against a formidable foe JO - Vaccine VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.06.088 DO - 10.1016/j.vaccine.2011.06.088 ID - Bilusic2011 ER - TY - JOUR AU - Lilja, H. AU - Ulmert, D. AU - Vickers, A. J. PY - 2008 DA - 2008// TI - Prostate-specific antigen and prostate cancer: prediction, detection and monitoring JO - Nat Rev VL - 8 UR - https://doi.org/10.1038/nrc2351 DO - 10.1038/nrc2351 ID - Lilja2008 ER - TY - JOUR AU - Pettersson, K. AU - Piironen, T. AU - Seppala, M. AU - Liukkonen, L. AU - Christensson, A. AU - Matikainen, M. T. AU - Suonpaa, M. AU - Lovgren, T. AU - Lilja, H. PY - 1995 DA - 1995// TI - Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex JO - Clin Chem VL - 41 ID - Pettersson1995 ER - TY - JOUR AU - Diamandis, E. P. PY - 1998 DA - 1998// TI - Prostate-specific antigen: its usefulness in clinical medicine JO - Trends Endocrinol Metab TEM VL - 9 UR - https://doi.org/10.1016/S1043-2760(98)00082-4 DO - 10.1016/S1043-2760(98)00082-4 ID - Diamandis1998 ER - TY - JOUR AU - Chen, Z. AU - Prestigiacomo, A. AU - Stamey, T. A. PY - 1995 DA - 1995// TI - Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays JO - Clin Chem VL - 41 ID - Chen1995 ER - TY - JOUR AU - Katzenwadel, A. AU - Schleer, H. AU - Gierschner, D. AU - Wetterauer, U. AU - Elsasser-Beile, U. PY - 2000 DA - 2000// TI - Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer JO - Anticancer Res VL - 20 ID - Katzenwadel2000 ER - TY - JOUR AU - Sinha, A. A. AU - Quast, B. J. AU - Reddy, P. K. AU - Elson, M. K. AU - Wilson, M. J. PY - 1999 DA - 1999// TI - Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice JO - Anticancer Res VL - 19 ID - Sinha1999 ER - TY - JOUR AU - Berlyn, K. A. AU - Schultes, B. AU - Leveugle, B. AU - Noujaim, A. A. AU - Alexander, R. B. AU - Mann, D. L. PY - 2001 DA - 2001// TI - Generation of CD4(+) and CD8(+) T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes JO - Clin Immunol (Orlando, Fla) VL - 101 UR - https://doi.org/10.1006/clim.2001.5115 DO - 10.1006/clim.2001.5115 ID - Berlyn2001 ER - TY - JOUR AU - Weiner, L. M. AU - Surana, R. AU - Wang, S. PY - 2010 DA - 2010// TI - Monoclonal antibodies: versatile platforms for cancer immunotherapy JO - Nat Rev Immunol VL - 10 UR - https://doi.org/10.1038/nri2744 DO - 10.1038/nri2744 ID - Weiner2010 ER - TY - STD TI - Helguera G, Daniels TR, Rodriguez JA, Penichet ML: Edited by: Flickinger M. 2010, New York: John Wiley & Sons, Inc, 3526-42. 5, Monoclonal antibodies In Human Engineered, Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology, ID - ref17 ER - TY - CHAP AU - Daniels, T. R. AU - Rodriguez, J. A. AU - Ortiz-Sanchez, O. AU - Helguera, G. AU - Penichet, M. L. ED - Penichet, M. L. ED - Jensen-Jarolim, E. PY - 2010 DA - 2010// TI - The IgE Antibody and Its Use in Cancer Immunotherapy BT - Cancer and IgE: Introducing the Concept of AllergoOncology PB - Springer CY - New York UR - https://doi.org/10.1007/978-1-60761-451-7_7 DO - 10.1007/978-1-60761-451-7_7 ID - Daniels2010 ER - TY - JOUR AU - Jensen-Jarolim, E. AU - Achatz, G. AU - Turner, M. C. AU - Karagiannis, S. AU - Legrand, F. AU - Capron, M. AU - Penichet, M. L. AU - Rodriguez, J. A. AU - Siccardi, A. G. AU - Vangelista, L. PY - 2008 DA - 2008// TI - AllergoOncology: the role of IgE-mediated allergy in cancer JO - Allergy VL - 63 UR - https://doi.org/10.1111/j.1398-9995.2008.01768.x DO - 10.1111/j.1398-9995.2008.01768.x ID - Jensen-Jarolim2008 ER - TY - JOUR AU - Kinet, J. P. PY - 1999 DA - 1999// TI - The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology JO - Annu Rev Immunol VL - 17 UR - https://doi.org/10.1146/annurev.immunol.17.1.931 DO - 10.1146/annurev.immunol.17.1.931 ID - Kinet1999 ER - TY - JOUR AU - Conrad, D. H. PY - 1990 DA - 1990// TI - Fc epsilon RII/CD23: the low affinity receptor for IgE JO - Annu Rev Immunol VL - 8 UR - https://doi.org/10.1146/annurev.iy.08.040190.003203 DO - 10.1146/annurev.iy.08.040190.003203 ID - Conrad1990 ER - TY - JOUR AU - Daniels, T. R. AU - Martinez-Maza, O. AU - Penichet, M. L. PY - 2012 DA - 2012// TI - Animal models for IgE-mediated cancer immunotherapy JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1169-1 DO - 10.1007/s00262-011-1169-1 ID - Daniels2012 ER - TY - BOOK AU - Penichet, M. L. AU - Jensen-Jarolim, E. PY - 2010 DA - 2010// TI - Cancer and IgE: introducing the concept of AllergoOncology PB - Springer CY - New York UR - https://doi.org/10.1007/978-1-60761-451-7 DO - 10.1007/978-1-60761-451-7 ID - Penichet2010 ER - TY - JOUR AU - Nigro, E. A. AU - Brini, A. T. AU - Soprana, E. AU - Ambrosi, A. AU - Dombrowicz, D. AU - Siccardi, A. G. AU - Vangelista, L. PY - 2009 DA - 2009// TI - Antitumor IgE adjuvanticity: key role of Fc epsilon RI JO - J Immunol VL - 183 UR - https://doi.org/10.4049/jimmunol.0900842 DO - 10.4049/jimmunol.0900842 ID - Nigro2009 ER - TY - JOUR AU - Daniels, T. R. AU - Leuchter, R. K. AU - Quintero, R. AU - Helguera, G. AU - Rodríguez, J. A. AU - Martínez-Maza, O. AU - Schultes, B. C. AU - Nicodemus, C. F. AU - Penichet, M. L. PY - 2012 DA - 2012// TI - Targeting HER2/neuwith a fully human IgE to harness the allergic reaction against cancer cells JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1150-z DO - 10.1007/s00262-011-1150-z ID - Daniels2012 ER - TY - JOUR AU - Hakimi, J. AU - Seals, C. AU - Kondas, J. A. AU - Pettine, L. AU - Danho, W. AU - Kochan, J. PY - 1990 DA - 1990// TI - The alpha subunit of the human IgE receptor (FceRI) is sufficient for high affinity IgE binding JO - J Biol Chem VL - 265 ID - Hakimi1990 ER - TY - JOUR AU - Wiegand, T. W. AU - Williams, P. B. AU - Dreskin, S. C. AU - Jouvin, M. H. AU - Kinet, J. P. AU - Tasset, D. PY - 1996 DA - 1996// TI - High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I JO - J Immunol VL - 157 ID - Wiegand1996 ER - TY - JOUR AU - Willis, R. A. AU - Bowers, W. J. AU - Turner, M. J. AU - Fisher, T. L. AU - Abdul-Alim, C. S. AU - Howard, D. F. AU - Federoff, H. J. AU - Lord, E. M. AU - Frelinger, J. G. PY - 2001 DA - 2001// TI - Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice JO - Hum Gene Ther VL - 12 UR - https://doi.org/10.1089/104303401753153929 DO - 10.1089/104303401753153929 ID - Willis2001 ER - TY - JOUR AU - Lyczak, J. B. AU - Zhang, K. AU - Saxon, A. AU - Morrison, S. L. PY - 1996 DA - 1996// TI - Expression of novel secreted isoforms of human immunoglobulin E proteins JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.7.3428 DO - 10.1074/jbc.271.7.3428 ID - Lyczak1996 ER - TY - JOUR AU - Xuan, C. AU - Steward, K. K. AU - Timmerman, J. M. AU - Morrison, S. L. PY - 2010 DA - 2010// TI - Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-10-250555 DO - 10.1182/blood-2009-10-250555 ID - Xuan2010 ER - TY - JOUR AU - Dombrowicz, D. AU - Brini, A. T. AU - Flamand, V. AU - Hicks, E. AU - Snouwaert, J. N. AU - Kinet, J. P. AU - Koller, B. H. PY - 1996 DA - 1996// TI - Anaphylaxis mediated through a humanized high affinity IgE receptor JO - J Immunol VL - 157 ID - Dombrowicz1996 ER - TY - JOUR AU - Dombrowicz, D. AU - Lin, S. AU - Flamand, V. AU - Brini, A. T. AU - Koller, B. H. AU - Kinet, J. P. PY - 1998 DA - 1998// TI - Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses JO - Immunity VL - 8 UR - https://doi.org/10.1016/S1074-7613(00)80556-7 DO - 10.1016/S1074-7613(00)80556-7 ID - Dombrowicz1998 ER - TY - JOUR AU - Fung-Leung, W. P. AU - De Sousa-Hitzler, J. AU - Ishaque, A. AU - Zhou, L. AU - Pang, J. AU - Ngo, K. AU - Panakos, J. A. AU - Chourmouzis, E. AU - Liu, F. T. AU - Lau, C. Y. PY - 1996 DA - 1996// TI - Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions JO - J Exp Med VL - 183 UR - https://doi.org/10.1084/jem.183.1.49 DO - 10.1084/jem.183.1.49 ID - Fung-Leung1996 ER - TY - JOUR AU - Bettler, B. AU - Hofstetter, H. AU - Rao, M. AU - Yokoyama, W. M. AU - Kilchherr, F. AU - Conrad, D. H. PY - 1989 DA - 1989// TI - Molecular structure and expression of the murine lymphocyte low-affinity receptor for IgE (Fc epsilon RII) JO - Proc Natl Acad Sci USA VL - 86 UR - https://doi.org/10.1073/pnas.86.19.7566 DO - 10.1073/pnas.86.19.7566 ID - Bettler1989 ER - TY - JOUR AU - Gould, H. J. AU - Sutton, B. J. PY - 2008 DA - 2008// TI - IgE in allergy and asthma today JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2273 DO - 10.1038/nri2273 ID - Gould2008 ER - TY - JOUR AU - Rafiq, K. AU - Bergtold, A. AU - Clynes, R. PY - 2002 DA - 2002// TI - Immune complex-mediated antigen presentation induces tumor immunity JO - J Clin Invest VL - 110 UR - https://doi.org/10.1172/JCI0215640 DO - 10.1172/JCI0215640 ID - Rafiq2002 ER - TY - JOUR AU - Rodriguez, A. AU - Regnault, A. AU - Kleijmeer, M. AU - Ricciardi-Castagnoli, P. AU - Amigorena, S. PY - 1999 DA - 1999// TI - Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells JO - Nat Cell Biol VL - 1 UR - https://doi.org/10.1038/14058 DO - 10.1038/14058 ID - Rodriguez1999 ER - TY - JOUR AU - Maurer, D. AU - Ebner, C. AU - Reininger, B. AU - Fiebiger, E. AU - Kraft, D. AU - Kinet, J. P. AU - Stingl, G. PY - 1995 DA - 1995// TI - The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation JO - J Immunol VL - 154 ID - Maurer1995 ER - TY - JOUR AU - Maurer, D. AU - Ebner, C. AU - Reininger, B. AU - Petzelbauer, P. AU - Fiebiger, E. AU - Stingl, G. PY - 1997 DA - 1997// TI - Mechanisms of Fc epsilon RI-IgE-facilitated allergen presentation by dendritic cells JO - Adv Exp Med Biol VL - 417 UR - https://doi.org/10.1007/978-1-4757-9966-8_29 DO - 10.1007/978-1-4757-9966-8_29 ID - Maurer1997 ER - TY - JOUR AU - Maurer, D. AU - Fiebiger, S. AU - Ebner, C. AU - Reininger, B. AU - Fischer, G. F. AU - Wichlas, S. AU - Jouvin, M. H. AU - Schmitt-Egenolf, M. AU - Kraft, D. AU - Kinet, J. P. PY - 1996 DA - 1996// TI - Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation JO - J Immunol VL - 157 ID - Maurer1996 ER - TY - JOUR AU - Bieber, T. PY - 1997 DA - 1997// TI - Fc epsilon RI on human epidermal Langerhans cells: an old receptor with new structure and functions JO - Int Arch Allergy Immunol VL - 113 UR - https://doi.org/10.1159/000237500 DO - 10.1159/000237500 ID - Bieber1997 ER - TY - JOUR AU - Van der Heijden, F. L. AU - Joost Van Neerven, R. J. AU - Van Katwijk, M. AU - Bos, J. D. AU - Kapsenberg, M. L. PY - 1993 DA - 1993// TI - Serum-IgE-facilitated allergen presentation in atopic disease JO - J Immunol VL - 150 ID - Van der Heijden1993 ER - TY - JOUR AU - Stevens, T. L. AU - Bossie, A. AU - Sanders, V. M. AU - Fernandez-Botran, R. AU - Coffman, R. L. AU - Mosmann, T. R. AU - Vitetta, E. S. PY - 1988 DA - 1988// TI - Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells JO - Nature VL - 334 UR - https://doi.org/10.1038/334255a0 DO - 10.1038/334255a0 ID - Stevens1988 ER - TY - JOUR AU - Helguera, G. AU - Dela Cruz, J. S. AU - Lowe, C. AU - Ng, P. P. AU - Trinh, R. AU - Morrison, S. L. AU - Penichet, M. L. PY - 2006 DA - 2006// TI - Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors JO - Vaccine VL - 24 UR - https://doi.org/10.1016/j.vaccine.2005.07.073 DO - 10.1016/j.vaccine.2005.07.073 ID - Helguera2006 ER - TY - JOUR AU - Nagy, E. AU - Berczi, I. AU - Sehon, A. H. PY - 1991 DA - 1991// TI - Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus JO - Cancer Immunol Immunother VL - 34 UR - https://doi.org/10.1007/BF01741326 DO - 10.1007/BF01741326 ID - Nagy1991 ER - TY - JOUR AU - Kershaw, M. H. AU - Darcy, P. K. AU - Trapani, J. A. AU - MacGregor, D. AU - Smyth, M. J. PY - 1998 DA - 1998// TI - Tumor-specific IgE-mediated inhibition of human colorectal carcinoma xenograft growth JO - Oncol Res VL - 10 ID - Kershaw1998 ER - TY - JOUR AU - Gould, H. J. AU - Mackay, G. A. AU - Karagiannis, S. N. AU - O’Toole, C. M. AU - Marsh, P. J. AU - Daniel, B. E. AU - Coney, L. R. AU - Zurawski, V. R. AU - Joseph, M. AU - Capron, M. PY - 1999 DA - 1999// TI - Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma JO - Eur J Immunol VL - 29 UR - https://doi.org/3.0.CO;2-5 DO - 3.0.CO;2-5 ID - Gould1999 ER - TY - JOUR AU - Karagiannis, S. N. AU - Wang, Q. AU - East, N. AU - Burke, F. AU - Riffard, S. AU - Bracher, M. G. AU - Thompson, R. G. AU - Durham, S. R. AU - Schwartz, L. B. AU - Balkwill, F. R. PY - 2003 DA - 2003// TI - Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells JO - Eur J Immunol VL - 33 UR - https://doi.org/10.1002/eji.200323185 DO - 10.1002/eji.200323185 ID - Karagiannis2003 ER - TY - JOUR AU - Karagiannis, S. N. AU - Bracher, M. G. AU - Hunt, J. AU - McCloskey, N. AU - Beavil, R. L. AU - Beavil, A. J. AU - Fear, D. J. AU - Thompson, R. G. AU - East, N. AU - Burke, F. PY - 2007 DA - 2007// TI - IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells JO - J Immunol VL - 179 UR - https://doi.org/10.4049/jimmunol.179.5.2832 DO - 10.4049/jimmunol.179.5.2832 ID - Karagiannis2007 ER - TY - JOUR AU - Karagiannis, S. N. AU - Bracher, M. G. AU - Beavil, R. L. AU - Beavil, A. J. AU - Hunt, J. AU - McCloskey, N. AU - Thompson, R. G. AU - East, N. AU - Burke, F. AU - Sutton, B. J. PY - 2008 DA - 2008// TI - Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells JO - Cancer Immunol Immunother VL - 57 UR - https://doi.org/10.1007/s00262-007-0371-7 DO - 10.1007/s00262-007-0371-7 ID - Karagiannis2008 ER - TY - JOUR AU - Karagiannis, P. AU - Singer, J. AU - Hunt, J. AU - Gan, S. K. AU - Rudman, S. M. AU - Mechtcheriakova, D. AU - Knittelfelder, R. AU - Daniels, T. R. AU - Hobson, P. S. AU - Beavil, A. J. PY - 2009 DA - 2009// TI - Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells JO - Cancer Immunol Immunother VL - 58 UR - https://doi.org/10.1007/s00262-008-0607-1 DO - 10.1007/s00262-008-0607-1 ID - Karagiannis2009 ER - TY - JOUR AU - Hoff, J. PY - 2000 DA - 2000// TI - Methods of blood collection in the mouse JO - Lab Anim VL - 29 ID - Hoff2000 ER - TY - JOUR AU - Gjertson, C. K. AU - Albertsen, P. C. PY - 2011 DA - 2011// TI - Use and assessment of PSA in prostate cancer JO - Med Clin North Am VL - 95 UR - https://doi.org/10.1016/j.mcna.2010.08.024 DO - 10.1016/j.mcna.2010.08.024 ID - Gjertson2011 ER - TY - JOUR AU - Zhang, W. M. AU - Finne, P. AU - Leinonen, J. AU - Stenman, U. H. PY - 2000 DA - 2000// TI - Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases JO - Scand J Clin Lab Invest VL - 233 UR - https://doi.org/10.1080/713783586 DO - 10.1080/713783586 ID - Zhang2000 ER - TY - JOUR AU - Sottrup-Jensen, L. AU - Petersen, T. E. AU - Magnusson, S. PY - 1981 DA - 1981// TI - Mechanism of proteinase complex formation with alpha 2-macroglobulin. Three modes of trypsin binding JO - FEBS Lett VL - 128 UR - https://doi.org/10.1016/0014-5793(81)81097-6 DO - 10.1016/0014-5793(81)81097-6 ID - Sottrup-Jensen1981 ER - TY - JOUR AU - Zhang, W. M. AU - Finne, P. AU - Leinonen, J. AU - Vesalainen, S. AU - Nordling, S. AU - Rannikko, S. AU - Stenman, U. H. PY - 1998 DA - 1998// TI - Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin JO - Clin Chem VL - 44 ID - Zhang1998 ER - TY - JOUR AU - Bheekha Escura, R. AU - Wasserbauer, E. AU - Hammerschmid, F. AU - Pearce, A. AU - Kidd, P. AU - Mudde, G. C. PY - 1995 DA - 1995// TI - Regulation and targeting of T-cell immune responses by IgE and IgG antibodies JO - Immunology VL - 86 ID - Bheekha Escura1995 ER - TY - JOUR AU - Chakraborty, N. G. AU - Stevens, R. L. AU - Mehrotra, S. AU - Laska, E. AU - Taxel, P. AU - Sporn, J. R. AU - Schauer, P. AU - Albertsen, P. C. PY - 2003 DA - 2003// TI - Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation JO - Cancer Immunol Immunother VL - 52 UR - https://doi.org/10.1007/s00262-003-0377-8 DO - 10.1007/s00262-003-0377-8 ID - Chakraborty2003 ER - TY - JOUR AU - Miller, A. M. AU - Ozenci, V. AU - Kiessling, R. AU - Pisa, P. PY - 2005 DA - 2005// TI - Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer JO - J Immunother VL - 28 UR - https://doi.org/10.1097/01.cji.0000165353.19171.41 DO - 10.1097/01.cji.0000165353.19171.41 ID - Miller2005 ER - TY - JOUR AU - Corman, J. M. AU - Sercarz, E. E. AU - Nanda, N. K. PY - 1998 DA - 1998// TI - Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells JO - Clin Exp Immunol VL - 114 UR - https://doi.org/10.1046/j.1365-2249.1998.00678.x DO - 10.1046/j.1365-2249.1998.00678.x ID - Corman1998 ER - TY - JOUR AU - Hsieh, C. S. AU - Macatonia, S. E. AU - O’Garra, A. AU - Murphy, K. M. PY - 1995 DA - 1995// TI - T cell genetic background determines default T helper phenotype development in vitro JO - J Exp Med VL - 181 UR - https://doi.org/10.1084/jem.181.2.713 DO - 10.1084/jem.181.2.713 ID - Hsieh1995 ER - TY - JOUR AU - Chu, R. S. AU - Targoni, O. S. AU - Krieg, A. M. AU - Lehmann, P. V. AU - Harding, C. V. PY - 1997 DA - 1997// TI - CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity JO - J Exp Med VL - 186 UR - https://doi.org/10.1084/jem.186.10.1623 DO - 10.1084/jem.186.10.1623 ID - Chu1997 ER - TY - JOUR AU - Nicodemus, C. F. AU - Wang, L. AU - Lucas, J. AU - Varghese, B. AU - Berek, J. S. PY - 2010 DA - 2010// TI - Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy JO - Am J Obstet Gynecol VL - 202 UR - https://doi.org/10.1016/j.ajog.2009.12.001 DO - 10.1016/j.ajog.2009.12.001 ID - Nicodemus2010 ER - TY - JOUR AU - Villoutreix, B. O. AU - Lilja, H. AU - Pettersson, K. AU - Lovgren, T. AU - Teleman, O. PY - 1996 DA - 1996// TI - Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building JO - Protein Sci VL - 5 UR - https://doi.org/10.1002/pro.5560050505 DO - 10.1002/pro.5560050505 ID - Villoutreix1996 ER - TY - JOUR AU - Kumar, V. AU - Hassan, M. I. AU - Kashav, T. AU - Singh, T. P. AU - Yadav, S. PY - 2008 DA - 2008// TI - Heparin-binding proteins of human seminal plasma: purification and characterization JO - Mol Reprod Dev VL - 75 UR - https://doi.org/10.1002/mrd.20910 DO - 10.1002/mrd.20910 ID - Kumar2008 ER - TY - JOUR AU - Kumar, V. AU - Hassan, M. I. AU - Tomar, A. K. AU - Kashav, T. AU - Nautiyal, J. AU - Singh, S. AU - Singh, T. P. AU - Yadav, S. PY - 2009 DA - 2009// TI - Proteomic analysis of heparin-binding proteins from human seminal plasma: a step towards identification of molecular markers of male fertility JO - J Biosci VL - 34 UR - https://doi.org/10.1007/s12038-009-0104-5 DO - 10.1007/s12038-009-0104-5 ID - Kumar2009 ER - TY - JOUR AU - Meyers, F. J. AU - Denardo, S. J. AU - Macey, D. AU - White, R. D. AU - Unger, M. PY - 1989 DA - 1989// TI - Development of monoclonal antibody imaging of metastatic prostatic carcinoma JO - Prostate VL - 14 UR - https://doi.org/10.1002/pros.2990140303 DO - 10.1002/pros.2990140303 ID - Meyers1989 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/13/195/prepub UR - http://www.biomedcentral.com/1471-2407/13/195/prepub ID - ref68 ER -